Skip to main content
. 2023 Jan;23(1):81–90. doi: 10.1016/S1473-3099(22)00492-3

Figure 1.

Figure 1

Trial profile

*Within the intention-to-treat population, there were 713 complete cases in the artemether–lumefantrine group and 714 complete cases in the multivitamin group.